How Long Does Nicotine Withdrawal Last?

The short answer: most physical withdrawal symptoms resolve within two to four weeks. Cravings last longer, but they change. The first week is the hardest. By month three, most people report that cravings are brief, infrequent and manageable. This is what the prospective studies show [1] [2], and it is a more useful answer than “it depends,” which is true but unhelpful when you are on day two and wondering if this ever ends.

Week by week

Week 1 (days 1-7). The most intense period. Cravings are frequent and can feel continuous. Irritability, anxiety, restlessness and difficulty concentrating peak around days three to five [1]. Sleep is often disrupted. Appetite increases. Some people describe a foggy, unfocused feeling that makes work and conversation harder. This is the week in which most unassisted quit attempts end.

The biological basis of the peak is straightforward. Nicotine has a half-life of roughly two hours, but the receptor adaptations it causes take days to begin reversing. When you stop smoking, nicotine clears from the bloodstream within 24-48 hours. The upregulated nicotinic receptors, which multiplied in response to chronic nicotine exposure, remain at elevated levels for days to weeks. The mismatch between no incoming nicotine and a receptor population that expects it produces the withdrawal syndrome. The peak at days three to five corresponds to the period of maximum receptor unoccupancy before downregulation begins.

Week 2 (days 8-14). The intensity drops noticeably. Cravings are still present but begin to space out: instead of a near-constant urge, there are stretches of an hour or more without one. Concentration improves. Sleep begins to normalize. Irritability is still present but less acute. Many people describe this week as “bad but better than week one.”

The cognitive symptoms, difficulty concentrating, slower processing speed, reduced working memory, typically improve during this week. Nicotine enhances certain cognitive functions through its action on prefrontal cortex receptors, and the withdrawal of that enhancement is measurable on cognitive tests in the first week. By week two, compensatory mechanisms begin to restore baseline performance [2]. Most people notice this as “the fog lifting,” though it happens gradually rather than all at once.

Weeks 3-4 (days 15-28). Most physical symptoms have resolved or diminished substantially. Cravings are increasingly tied to specific triggers, situations or times of day, rather than being a baseline state. Appetite may still be elevated. Some people notice an improvement in taste and smell during this period, which is pleasant but can be disorienting.

By week four, the physiological withdrawal is largely over for most people. The symptoms that remain are primarily conditioned responses: the brain has learned to associate specific contexts (finishing a meal, starting the car, taking a coffee break) with smoking, and these associations produce craving in those contexts even after the neurochemical withdrawal has resolved. This is a different mechanism from the first week’s constant pull, and it responds to different strategies (avoidance, substitution, extinction through repeated exposure without smoking).

Months 2-3. Episodic cravings continue but are typically brief, lasting minutes rather than hours [3]. The triggers become predictable: after a meal, with alcohol, during a stressful conversation, in a social group where others smoke. Between triggers, many people report no craving at all for hours or days.

The character of cravings at this stage is qualitatively different from week one. Early withdrawal cravings are diffuse and physiological: a background state that affects everything. Two-month cravings are specific and psychological: a thought that arrives in a particular context, intensifies briefly and passes. Ecological momentary assessment data, where participants report cravings in real time via electronic diaries rather than recalling them later, confirms this pattern [3]. The intensity of individual craving episodes does not necessarily decrease (some two-month cravings are rated as strong), but their frequency and duration decrease substantially.

Months 3-6 and beyond. Cravings continue to decline in frequency. Most people who remain smoke-free past three months report that cravings are manageable. Occasional strong cravings can occur unexpectedly, even months later, often in novel situations that catch the person off guard: a holiday setting you have not encountered since quitting, a specific stressor that mirrors the conditions under which you used to smoke, or exposure to someone smoking in a context that bypasses your usual coping.

These late cravings are normal and do not indicate a return to acute withdrawal. They are conditioned responses to contexts that were not encountered during the initial extinction period. They pass, typically in minutes, and they do not carry the physiological intensity of early withdrawal. The practical risk is not that the craving overwhelms you physically but that it catches you in a moment of low resolve or high stress when the decision to smoke feels easy rather than costly.

What lasts longest

Increased appetite and associated weight gain are the most persistent changes. The appetite-suppressing effect of nicotine lifts with cessation, and many people gain 4-5 kg in the first year after quitting. This is not a withdrawal symptom in the traditional sense but a return to a baseline that nicotine was suppressing. The metabolic rate also decreases slightly after cessation: nicotine raises resting metabolic rate by roughly 5-10%, and this effect reverses when nicotine intake stops. The combination of increased appetite and decreased metabolic rate explains why the weight gain is common and why it persists longer than other post-cessation changes.

The weight gain, while real, is clinically minor compared to the cardiovascular, pulmonary and cancer risk reduction from quitting. The health benefit of cessation outweighs the health cost of a few kilograms of weight gain by a wide margin. For people who are concerned about weight, the evidence supports continuing NRT beyond the standard course as a weight-management strategy: nicotine from NRT continues to provide some appetite suppression and metabolic effect without the combustion products of cigarettes.

Cravings are the other long-duration phenomenon. Ecological momentary assessment studies, which track cravings in real time rather than relying on recall, show that individual craving episodes at three months are brief but can be intense [3]. They are qualitatively different from the week-one experience: specific rather than general, situational rather than constant.

The withdrawal-relapse connection

The relationship between withdrawal severity and relapse is not as straightforward as it might seem. Prospective tracking studies show that the trajectory of withdrawal symptoms, whether they are improving or worsening on a given day, predicts relapse better than the absolute severity level [4]. A person whose symptoms are moderate but worsening is at higher risk than a person whose symptoms are severe but improving. This suggests that it is the trend, rather than the level, that drives the decision to smoke.

The combination of persistent cravings and negative mood is the strongest predictor of relapse during the withdrawal period [4]. People who experience both are at substantially higher risk of relapse in the first two weeks than people who experience one or the other. This has a practical implication: methods that address both cravings (NRT, varenicline) and mood (bupropion, behavioral support) simultaneously may be more protective during the critical window than methods that address only one.

How quit methods change the timeline

Cold turkey produces the sharpest withdrawal curve: rapid onset, high peak, relatively quick resolution of physical symptoms. NRT flattens the curve: lower peak intensity, longer taper, mild secondary withdrawal when NRT itself is stopped. Varenicline produces a different pattern: withdrawal is reduced from the start because the drug partially activates the nicotine receptor, and the character of cravings changes (they feel less urgent) [5].

Method	Peak intensity	Duration of physical symptoms	Craving pattern	Notes
Cold turkey	High (days 3-5)	2-4 weeks	Constant then episodic	Sharpest curve
Single NRT	Moderate	Extended taper + mild secondary	Reduced background, episodic breakthrough	Patch flattens the curve
Combination NRT	Lower	Extended taper + mild secondary	Background covered, breakthrough blunted	Patch + gum/lozenge covers both components
Varenicline	Low-moderate	Reduced from start, resolves with drug taper	Changed character, less urgent	Partial agonism reduces withdrawal differently
Bupropion	Moderate	2-3 weeks, some mood protection	Reduced intensity, mood component addressed	Also helps with negative affect

People who use NRT sometimes worry that they are “just moving the addiction.” The evidence does not support this concern for most users. NRT delivers nicotine at lower levels and without the rapid peaks that reinforce addiction. The patch provides a steady-state level roughly equivalent to a light smoker, not the sharp peaks a cigarette delivers in seven to ten seconds. The transition off NRT, when managed with a taper, is typically milder than cold-turkey withdrawal from cigarettes. A small percentage of people do continue NRT long-term, particularly gum, but long-term NRT use carries vastly less health risk than continued smoking.

What predicts a harder withdrawal

Higher baseline nicotine dependence (measured by cigarettes per day, time to first cigarette, or the Fagerstrom scale) is associated with more severe withdrawal, but the correlation is only moderate [1]. Some lighter smokers have difficult withdrawals; some heavier smokers find it surprisingly manageable. Prior quit-attempt experience is also not a reliable predictor: having had a severe withdrawal before does not guarantee the same pattern, especially with pharmacological support.

Other factors that are associated with more difficult withdrawal include: concurrent stressors during the quit attempt, lower social support, history of depression or anxiety (nicotine may have been partially self-medicating mood), and alcohol use in the first weeks (alcohol is both a trigger for cravings and a reducer of inhibition against smoking). None of these factors are absolute predictors, and all of them can be addressed with planning, support and appropriate pharmacological treatment.

What this means if you’re deciding

The withdrawal timeline is finite and well characterized. Knowing that the peak is days three to five, and that the most difficult period is the first week, allows you to plan: clear the calendar where possible, have NRT or a prescription in place before you start, arrange support for the hardest days rather than hoping willpower covers it.

If you have quit before and the withdrawal was the reason you restarted, that information is useful for selecting a method. A method that reduces withdrawal intensity (combination NRT, varenicline) changes the experience meaningfully and improves your odds of getting through the peak without relapsing. The comparison table above shows the different curves: if cold turkey’s sharp peak was what broke the last attempt, a flatter curve may be what the next attempt needs.

For smokers with COPD, the withdrawal period is the same, but the clinical benefit of getting through it is larger. The lung function that is preserved by quitting is not recovered; it is protected from further decline. Every day of withdrawal is working toward that. In this population, using the highest-efficacy method from the start is the most protective strategy, because every failed attempt means additional weeks or months of continued smoking and continued FEV1 decline that cannot be reversed.

A doctor or pharmacist can help choose the right approach for your health history. The Quitline (1-800-QUIT-NOW) provides free coaching and can sometimes supply NRT.